
Preparing Rare Disease Manufacturers for JCA: The Role of Early Stakeholder Engagement
Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.
Home > Education Hub > Articles

Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.

Learn where patient involvement fits within JSC and JCA under EU HTA Regulation and how to prepare your engagement strategy.

Explore how registries in rare disease trial recruitment connect sponsors with patient communities to improve identification and enrollment.

Explore how data management FSP strengthens governance, visibility, and efficiency across multi-vendor trials for more confident execution.

Learn what clinical trial excellence means in complex product development and how biotech leaders can manage new complexity, risk, and executional pressure.

Learn how biologics CDMO leaders strengthen competitive advantage in 2026 with resilient networks, AI-driven execution, and disciplined capital strategies.